UBS Group »

Tvardi Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.9M 49k 38.95
2025-06-30 $685k 29k 23.34